Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q2 EPS of ($1.09), $1.26 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.11 billion.

For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.